Načítá se...
去甲氧柔红霉素联合阿糖胞苷治疗初发急性髓系白血病的预后分析
OBJECTIVE: To explore outcomes in adult with de novo acute myeloid leukemia (AML) received IA10 (10 mg/m(2) d1–3 idarubicin plus cytarabine 100 mg/m(2) d1–7) regimen as induction chemotherapy. METHODS: From January 2008 to February 2016, data of consecutive newly-diagnosed AML (non-M(3)) adults trea...
Uloženo v:
| Vydáno v: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Editorial office of Chinese Journal of Hematology
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7343116/ https://ncbi.nlm.nih.gov/pubmed/29551027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.01.004 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|